Abstract
Prostate cancer is the most common malignant tumor in men and the second leading cause of cancer death in Western countries. With the advent of prostate specific antigen (PSA) and the adoption of screening programs there was clearly an increased detection of the disease at an earlier stage. Tumor diagnosis is established by prostate biopsy that is usually guided by transrectal ultrasonogr…